Mg. Henderson et al., POSSIBLE INVOLVEMENT OF DOPAMINE IN THE LONG-TERM SEROTONIN DEPLETIONBY P-CHLOROAMPHETAMINE AND BETA,BETA-DIFLUORO-P-CHLOROAMPHETAMINE IN RATS, The Journal of pharmacology and experimental therapeutics, 267(1), 1993, pp. 417-424
The role of dopamine in the long-term depletion of serotonin in rat br
ain by p-chloroamphetamine (PCA) and related compounds was investigate
d by comparing effects of beta,beta-difluoro-p-chloroamphetamine (beta
,beta-difluoro-PCA) and 4-methyl-alpha-ethyl-meta-tyramine (H75/12), r
eported to cause only short-term serotonin depletion, with those of PC
A. A single dose of beta,beta-difluoro-PCA had no long-term effects on
serotonin in whole rat brain, even after pretreatment with proadifen
which decreased the rate at which beta,beta-difluoro-PCA disappeared f
rom brain. The possibility that proadifen might antagonize serotonin d
epletion was ruled out; proadifen did not prevent long-term serotonin
depletion by PCA. Long-term depletion of brain serotonin was found aft
er repeated injections of beta,beta-difluoro-PCA (five injections 4 hr
apart) and was prevented by fluoxetine pretreatment. 3,3-Difluoro-PCA
given after the monoamine oxidase inhibitor pargyline or after carbid
opa/L-dopa also caused long-term serotonin depletion, although H75/12
did not. At early times after single doses producing the same initial
depletion of serotonin, PCA caused a large increase in dopamine and a
large decrease in the metabolite 3,4-dihydroxyphenylacetic acid in who
le brain, thereby increasing the ratio dopamine/3,4-dihydroxyphenylace
tic, and the other two drugs caused smaller effects. Extracellular dop
amine was increased markedly by PCA, less by beta,beta-difluoro-PCA, a
nd not at all by H75/12. These results suggest an association between
dopamine release and long-term depletion of serotonin and add to evide
nce that dopamine release by PCA may be essential to its neurotoxic ac
tions on brain serotonin neurons.